Royal Bank of Canada’s iShares Biotechnology ETF IBB Stock Holding History

Royal Bank of Canada’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-45,700	Closed	-$6.21M	–	7253
2023 Q4	$6.21M	Buy	+45,700	New	+$5.58M	﹤0.01%	2086
2021 Q1	–	Sell	-1,000	Closed	-$151K	–	7536
2020 Q4	$151K	Hold	1,000	–	–	﹤0.01%	5061
2020 Q3	$135K	Hold	1,000	–	–	﹤0.01%	4798
2020 Q2	$137K	Hold	1,000	–	–	﹤0.01%	4664
2020 Q1	$108K	Sell	1,000 -100,000	-99%	-$11.5M	﹤0.01%	4728
2019 Q4	$12.2M	Hold	101,000	–	–	﹤0.01%	1490
2019 Q3	$10.1M	Sell	101,000 -600	-0.6%	-$62.8K	﹤0.01%	1571
2019 Q2	$11.1M	Buy	101,600 +600	+0.6%	+$63.8K	﹤0.01%	1487
2019 Q1	$11.3M	Buy	+101,000	New	+$11.1M	﹤0.01%	1441
2018 Q1	–	Sell	-71,700	Closed	-$7.66M	–	6536
2017 Q4	$7.66M	Hold	71,700	–	–	﹤0.01%	1781
2017 Q3	$7.97M	Hold	71,700	–	–	﹤0.01%	1688
2017 Q2	$7.41M	Hold	71,700	–	–	﹤0.01%	1707
2017 Q1	$7.01M	Buy	71,700 +54,900	+327%	+$5.26M	﹤0.01%	1697
2016 Q4	$1.49M	Sell	16,800 -900	-5%	-$81.9K	﹤0.01%	2815
2016 Q3	$1.71M	Sell	17,700 -1,108,800	-98%	-$105M	﹤0.01%	2670
2016 Q2	$96.6M	Buy	1,126,500 +1,050,000	+1,373%	+$94.2M	0.06%	267
2016 Q1	$6.65M	Sell	76,500 -22,800	-23%	-$2.04M	﹤0.01%	1632
2015 Q4	$11.2M	Sell	99,300 -54,000	-35%	-$5.86M	0.01%	1354
2015 Q3	$15.5M	Buy	153,300 +3,300	+2%	+$396K	0.01%	906
2015 Q2	$18.4M	Buy	+150,000	New	+$18M	0.01%	870
2013 Q3	–	Sell	-60,000	Closed	-$3.48M	–	6166
2013 Q2	$3.48M	Buy	+60,000	New	+$3.47M	﹤0.01%	1695

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada's IBB Position: Q1 2026 in Review

Royal Bank of Canada increased its iShares Biotechnology ETF (IBB) stake by 1% in Q1 2026, buying an estimated $1.27M and bringing the position to 737,128 shares worth $124M. The position accounts for 0.02% of the portfolio, ranked #567.

Royal Bank of Canada first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $240M in Q4 2022. 921 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Royal Bank of Canada held 737,128 shares of iShares Biotechnology ETF worth $124M as of Q1 2026.
Royal Bank of Canada bought 7,434 iShares Biotechnology ETF shares in Q1 2026, an estimated $1.27M.
iShares Biotechnology ETF made up 0.02% of Royal Bank of Canada's portfolio in Q1 2026, its #567 holding.
Royal Bank of Canada first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
Royal Bank of Canada's iShares Biotechnology ETF position peaked at $240M in Q4 2022.
921 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.